Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in REGENERON PHARMACEUTICALS
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 745,233 shares of REGN (REGENERON PHARMACEUTICALS), worth $575.2M as of 2025-Q4. The position was increased (++0.1% shares). REGN represents 0.1% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$575.2M
Current Shares
745,233
Total Value Change
-$315.7M
Total Shares Change
-102,449
Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS
Increased |
| 745,233 |
+0.1% |
| $575.2M |
| 0.1% |
| $773.94 |
38 |
| 2025-Q3 | Decreased | 744,173 | -13.5% | $418.4M | 0.1% | $560.05 | 0 |
| 2025-Q2 | Decreased | 860,441 | -8.5% | $451.7M | 0.1% | $519.56 | 0 |
| 2025-Q1 | Decreased | 940,336 | -4.3% | $596.4M | 0.2% | $634.66 | 0 |
| 2024-Q4 | Increased | 982,064 | +30.1% | $699.6M | 0.2% | $698.71 | 48 |
| 2024-Q3 | Decreased | 755,112 | -10.9% | $793.8M | 0.2% | $1,036.94 | 0 |
| 2024-Q2 | Increased | 847,682 | +23.8% | $890.9M | 0.3% | $1,045.23 | 46 |